Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bowel prep boost? study pulled before starting

NCT ID NCT04361656

Knowledge-focused Sponsor: Henry Ford Health System Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study was designed to see if adding a medication called lubiprostone to the standard bowel-cleansing drink helps hospital patients get a better colonoscopy prep. It planned to compare prep quality before and after adding the drug in about 200 adults. However, the study was withdrawn before enrolling anyone, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Started

May 2020

Finished

Feb 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Hospital patients having colonoscopy performed

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Is scheduled for colonoscopy evaluation during his hospitalization to one of the trial sites (SJPH, PPH, or SJMH). * Has a negative urine pregnancy test (hCG) for female of reproductive age. * Provide an Informed Consent / has a legally acceptable representative capable of understanding the Informed Consent document and providing consent on the participant's behalf. * Provide a separate signed and dated Informed Consents for colonoscopy procedure and anaesthesia administration as per site policy. Exclusion Criteria: * Has a documented or suspected bowel obstruction (small bowel obstruction, volvulus, gastric outlet obstruction, ileus, or toxic megacolon). * Has a documented gastroparesis. * Has severe diarrhea (\>8 bowel movements per day). * Has severe encephalopathy or obtunded (GCS \< 13). * Has a documented or suspected acute coronary syndrome or recent myocardial infarction within 12 weeks prior to enrollment. * Has renal impairment with GFR less than 30 ml/min/1.73 m2 on the day of enrollment (end-stage renal disease on renal replacement therapy can be enrolled). * Has severe liver impairment with Child-Pugh class B or C. * Has symptomatic heart failure (NYHA class III or IV) or prohibitive pre-procedure cardiac risk (documented by primary team or cardiology prior to enrollment). * Has a known hypersensitivity to Lubiprostone or its class. * Is pregnant or lactating.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colonoscopy preparation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colonoscopy preparation

Contacts and locations

Locations

  • Ascension Macomb-Oakland Hospital

    Warren, Michigan, 48093, United States

  • Ascension Providence Hopsital (Novi)

    Novi, Michigan, 48374, United States

  • Ascension Providence Hospital, Southfield Campus

    Southfield, Michigan, 48075, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.